Pharmafile Logo
Pharmafocus logo
Advanced Search

als

Showing 10 posts of 10 posts found.

shutterstock_159488225

New treatment could extend survival in amyotrophic lateral sclerosis patients

October 20, 2020
Manufacturing and Production, Research and Development als, pharma

Research into an experimental drug combination shows that it could potentially extend the lives for sufferers of amyotrophic lateral sclerosis …

News
shutterstock_159488225

Astellas and Cytokinetics’ reldesemtiv falls short at Phase 2 in ALS

May 7, 2019
Manufacturing and Production, Sales and Marketing Astellas, als, amyotrophic lateral sclerosis, cytokinetics, pharma

Cytokinetics has announced at the American Academy of Neurology (AAN) that its fast skeletal muscle troponin activator (FSTA) reldesemtiv fell …

News
shutterstock_138095450

Aquinnah Pharmaceuticals receives $3.4 million grant to advance ALS therapies

June 21, 2018
Research and Development, Sales and Marketing Aquinnah Pharmaceuticals, als, amyotrophic lateral sclerosis, pharma

Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders …

News
ema_building_face_web

AB Science will not seek review of masitinib rejection in Europe

May 29, 2018
Manufacturing and Production, Sales and Marketing EMA, Europe, ab science, als, masitinib, pharma

AB Science has U-turned on its pursuit of a do-over on its marketing application of masitinib in Europe after the …

News
credit_-_daniel_leal-olivas-afp

CHMP rejects AB Science’s ALS therapy in Europe

April 23, 2018
Sales and Marketing AB Sciences, EMA, European Medicines Agency, ab science, als, masitinib, pharma

AB Science has revealed that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …

News

FDA approves first ALS/Lou Gehrig’s disease therapy in 22 years

May 18, 2017
Research and Development, Sales and Marketing Mitsubishi Tanabe Pharma, als

The FDA has announced that it has approved Mitsubishi Tanabe Pharma’s Radicava (edaravone) for the treatment of amyotrophic lateral sclerosis(ALS), …

News
ema_inside

New therapy wins EMA orphan drug designation for ALS

August 9, 2016
Manufacturing and Production, Research and Development EMA, Ice Bucket Challenge, ab science, als, masitinib, oprhan drug designation

French pharma company AB Science has announced that the European Medicines Agency has granted orphan drug status to masitinib for …

News
Eisai image

Eisai seeks new ALS drug approval

May 28, 2015
Sales and Marketing Eisai, Japan, als, mecobalamin

Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …

News
donald_johns_biogen_idec

Biogen Idec hires from Novartis to head ALS

September 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Novartis, als, donald johns

Biogen Idec has appointed Dr Donald Johns as the vice president of its amyotrophic lateral sclerosis (ALS) innovation hub unit. …

Appointment
lilly image

Lilly signs Lou Gehrig’s disease deal

November 21, 2013
Research and Development, Sales and Marketing als, hill, lilly, lou gehrig

Eli Lilly & Company has signed a deal with US charity Project A.L.S. to find new treatments for the debilitating …

News

Latest content

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023

NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment

September 27, 2023

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023